284 related articles for article (PubMed ID: 18648775)
1. An in vitro model for assessment of drug-induced torsade de pointes arrhythmia : effects of haloperidol and dofetilide on potential duration, repolarization inhomogeneities, and torsade de pointes arrhythmia.
Dhein S; Perlitz F; Mohr FW
Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):631-44. PubMed ID: 18648775
[TBL] [Abstract][Full Text] [Related]
2. Importance of extracardiac alpha1-adrenoceptor stimulation in assisting dofetilide to induce torsade de pointes in rabbit hearts.
Farkas AS; Acsai K; Tóth A; Dézsi L; Orosz S; Forster T; Csanády M; Papp JG; Varró A; Farkas A
Eur J Pharmacol; 2006 May; 537(1-3):118-25. PubMed ID: 16618484
[TBL] [Abstract][Full Text] [Related]
3. The role of the Na+/Ca2+ exchanger, I(Na) and I(CaL) in the genesis of dofetilide-induced torsades de pointes in isolated, AV-blocked rabbit hearts.
Farkas AS; Makra P; Csík N; Orosz S; Shattock MJ; Fülöp F; Forster T; Csanády M; Papp JG; Varró A; Farkas A
Br J Pharmacol; 2009 Mar; 156(6):920-32. PubMed ID: 19222480
[TBL] [Abstract][Full Text] [Related]
4. Ventricular remodelling is a prerequisite for the induction of dofetilide-induced torsade de pointes arrhythmias in the anaesthetized, complete atrio-ventricular-block dog.
Dunnink A; van Opstal JM; Oosterhoff P; Winckels SK; Beekman JD; van der Nagel R; Cora Verduyn S; Vos MA
Europace; 2012 Mar; 14(3):431-6. PubMed ID: 21946817
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes.
Wu Y; Carlsson L; Liu T; Kowey PR; Yan GX
J Cardiovasc Electrophysiol; 2005 Aug; 16(8):898-904. PubMed ID: 16101634
[TBL] [Abstract][Full Text] [Related]
6. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
Van Opstal JM; Leunissen JD; Wellens HJ; Vos MA
Eur J Pharmacol; 2001 Jan; 412(1):67-76. PubMed ID: 11166738
[TBL] [Abstract][Full Text] [Related]
7. Effects of K201 on repolarization and arrhythmogenesis in anesthetized chronic atrioventricular block dogs susceptible to dofetilide-induced torsade de pointes.
Stams TR; Oros A; der Nagel Rv; Beekman JD; Chamberlin P; Dittrich HC; Vos MA
Eur J Pharmacol; 2011 Dec; 672(1-3):126-34. PubMed ID: 22001562
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
Liu G; Xue X; Gao C; Huang J; Qi D; Zhang Y; Dong JZ; Ma CS; Yan GX
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522677
[TBL] [Abstract][Full Text] [Related]
9. Progesterone pretreatment reduces the incidence of drug-induced torsades de pointes in atrioventricular node-ablated isolated perfused rabbit hearts.
Tisdale JE; Jaynes HA; Overholser BR; Sowinski KM; Kovacs RJ
J Cardiovasc Electrophysiol; 2019 Jun; 30(6):941-949. PubMed ID: 31006943
[TBL] [Abstract][Full Text] [Related]
10. Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence.
Barrett TD; Hennan JK; Fischbach PS; O'Neill BP; Driscoll EM; Lucchesi BR
Br J Pharmacol; 2001 Apr; 132(7):1493-500. PubMed ID: 11264243
[TBL] [Abstract][Full Text] [Related]
11. Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies.
Jaiswal A; Goldbarg S
Indian Heart J; 2014; 66(6):640-8. PubMed ID: 25634399
[TBL] [Abstract][Full Text] [Related]
12. Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.
Naksuk N; Sugrue AM; Padmanabhan D; Kella D; DeSimone CV; Kapa S; Asirvatham SJ; Lee HC; Ackerman MJ; Noseworthy PA
J Interv Card Electrophysiol; 2019 Mar; 54(2):189-196. PubMed ID: 30353374
[TBL] [Abstract][Full Text] [Related]
13. Models of torsades de pointes: effects of FPL64176, DPI201106, dofetilide, and chromanol 293B in isolated rabbit and guinea pig hearts.
Cheng HC; Incardona J
J Pharmacol Toxicol Methods; 2009; 60(2):174-84. PubMed ID: 19524054
[TBL] [Abstract][Full Text] [Related]
14. Slow delayed rectifier K+ current block by HMR 1556 increases dispersion of repolarization and promotes Torsades de Pointes in rabbit ventricles.
So PP; Backx PH; Dorian P
Br J Pharmacol; 2008 Dec; 155(8):1185-94. PubMed ID: 18836478
[TBL] [Abstract][Full Text] [Related]
15. Effects of class III antiarrhythmic agents in an in vitro rabbit model of spontaneous torsades de pointe.
D'Alonzo AJ; Zhu JL; Darbenzio RB
Eur J Pharmacol; 1999 Mar; 369(1):57-64. PubMed ID: 10204682
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological mechanism of enhanced susceptibility of hypertrophied heart to acquired torsade de pointes arrhythmias: tridimensional mapping of activation and recovery patterns.
Kozhevnikov DO; Yamamoto K; Robotis D; Restivo M; El-Sherif N
Circulation; 2002 Mar; 105(9):1128-34. PubMed ID: 11877367
[TBL] [Abstract][Full Text] [Related]
17. AV-block and conduction slowing prevail over TdP arrhythmias in the methoxamine-sensitized pro-arrhythmic rabbit model.
Varkevisser R; Vos MA; Beekman JD; Tieland RG; Van Der Heyden MA
J Cardiovasc Electrophysiol; 2015 Jan; 26(1):82-9. PubMed ID: 25154623
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers and endogenous determinants of dofetilide-induced torsades de pointes in α(1) -adrenoceptor-stimulated, anaesthetized rabbits.
Farkas AS; Rudas L; Makra P; Csík N; Leprán I; Forster T; Csanády M; Papp JG; Varró A; Farkas A
Br J Pharmacol; 2010 Dec; 161(7):1477-95. PubMed ID: 20659107
[TBL] [Abstract][Full Text] [Related]
19. Ultrafast sodium channel block by dietary fish oil prevents dofetilide-induced ventricular arrhythmias in rabbit hearts.
Dujardin KS; Dumotier B; David M; Guizy M; Valenzuela C; Hondeghem LM
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1414-21. PubMed ID: 18676685
[TBL] [Abstract][Full Text] [Related]
20. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
